Nobel Award Recognizes Groundbreaking Immune System Research

The Nobel Prize in Physiology or Medicine was awarded for revolutionary findings that illuminate how the immune system targets harmful pathogens while protecting the body's own cells.

Three esteemed researchers—Japan's Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this honor.

Their research uncovered unique "sentinels" within the defense system that remove rogue defense cells that could attacking the organism.

These discoveries are now paving the way for new therapies for autoimmune diseases and malignancies.

The laureates will divide a monetary award worth 11m SEK.

Decisive Findings

"Their work has been decisive for understanding how the immune system functions and why we do not all develop severe self-attack conditions," stated the chair of the Nobel Committee.

The team's research address a fundamental mystery: In what way does the immune system defend us from numerous invaders while keeping our healthy cells intact?

The body's protection system employs white blood cells that search for indicators of disease, including pathogens and germs it has not met before.

Such defenders employ detectors—called recognition units—that are produced randomly in a vast number of combinations.

This provides the defense network the capacity to combat a wide array of threats, but the unpredictability of the mechanism inevitably produces immune cells that may attack the host.

Security Guards of the Immune System

Scientists previously knew that a portion of these problematic white blood cells were destroyed in the immune organ—the site where white blood cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the system to neutralize any defenders that assault the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee stated, "The discoveries have laid the foundation for a novel area of research and spurred the development of innovative treatments, for instance for tumors and autoimmune diseases."

Regarding cancer, T-regs prevent the system from attacking the growth, so research are aimed at lowering their numbers.

In autoimmune diseases, trials are testing boosting regulatory T-cells so the body is not being harmed. A similar approach could also be useful in reducing the risks of transplanted organ failure.

Pioneering Experiments

Professor Sakaguchi, of Osaka University, conducted tests on mice that had their immune gland extracted, leading to self-attack conditions.

He showed that injecting immune cells from other animals could prevent the disease—suggesting there was a system for preventing immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in mice and humans that led to the identification of a gene vital for the way T-regs operate.

"Their groundbreaking work has uncovered how the immune system is controlled by regulatory T cells, stopping it from mistakenly targeting the body's own tissues," said a prominent biological science expert.

"The research is a striking illustration of how basic physiological research can have far-reaching implications for public health."